Elanco (ELAN) executive uses 8,262 shares in tax-withholding stock disposition

Rhea-AI Filing Summary

Elanco Animal Health Inc executive Ellen de Brabander reported a tax-related stock transaction. On this Form 4, she disposed of 8,262 shares of Common Stock on March 3, 2026 through a tax-withholding disposition at a price of $24.88 per share, leaving her with 260,124 directly owned shares.

Insider Trade Summary

Net Seller: 8,262 shares

Net Sell 1 txn

Insider de Brabander Ellen

Role SEE REMARKS

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	8,262	$24.88	$206K

Holdings After Transaction: Common Stock — 260,124 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 04:12 PM Learn about SEC filing dates

FAQ

What insider transaction did Ellen de Brabander report at Elanco Animal Health (ELAN)?

Ellen de Brabander reported a tax-withholding disposition of Elanco Animal Health common stock. She disposed of 8,262 shares on March 3, 2026 at $24.88 per share, as payment of exercise price or tax liability, rather than an open-market sale.

How many Elanco (ELAN) shares did Ellen de Brabander dispose of for taxes?

She disposed of 8,262 shares of Elanco Animal Health common stock. The transaction was coded as a tax-withholding disposition, meaning shares were used to cover exercise price or tax liability instead of being sold in a discretionary market transaction.

What was the price per share in Ellen de Brabander’s Elanco (ELAN) tax-withholding transaction?

The tax-withholding disposition used a price of $24.88 per share for 8,262 Elanco Animal Health common shares. This value is used to calculate the amount applied toward exercise price or tax liability associated with the underlying equity award.

How many Elanco (ELAN) shares does Ellen de Brabander hold after this Form 4 transaction?

After the reported tax-withholding disposition, Ellen de Brabander directly owns 260,124 Elanco Animal Health common shares. This post-transaction balance reflects her remaining direct equity stake following the 8,262-share disposition for tax or exercise-price obligations.

Was Ellen de Brabander’s Elanco (ELAN) Form 4 transaction a market sale or tax withholding?

The Form 4 describes the transaction as a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy exercise price or tax liability, as indicated by transaction code F and the accompanying description of payment via delivering securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

de Brabander Ellen

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		8,262	D	$24.88	260,124	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Executive Vice President, Research, Development and Regulatory Affairs

	/s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.